11/9/2021 8:39:23 PM
Chinook Therapeutics Prices Upsized Underwritten Public Offering Of 7.83 Mln Shares At $14.00/shr
6/9/2021 8:32:42 AM
Chinook Therapeutics Promotes Tom Frohlich To COO And Andrew King To Chief Scientific Officer
6/8/2021 8:32:19 AM
Chinook Therapeutics Presents BION-1301 Interim Phase 1/2 Data In Patients With IgA Nephropathy At ERA-EDTA Congress
2/2/2021 8:29:18 AM
Chinook Receives Rare Pediatric Disease Designation From FDA For CHK-336 For Treatment Of Primary Hyperoxaluria
10/2/2017 10:22:31 AM
William Blair Reiterates Aduro Biotech Inc. (ADRO) At Outperform
3/2/2017 8:46:50 AM
William Blair Is Increasing Aduro Biotech Inc. (ADRO) 2019 Estimate To -1.89 From -1.99
3/2/2017 8:46:36 AM
William Blair Is Increasing Aduro Biotech Inc. (ADRO) 2018 Estimate To -1.88 From -1.96
3/2/2017 8:46:23 AM
William Blair Is Increasing Aduro Biotech Inc. (ADRO) 2017 Estimate To -1.50 From -1.57